VIDA Companies

A Lung and Respiratory Intelligence Company. VIDA IS ACCELERATING RESPIRATORY CLINICAL TRIALS THROUGH INTELLIGENCE See How COVID-19 Asthma COPD ILD Cancer Emphysema Respiratory clinical trials are costly and inefficient, Our mission is to accelerate therapies to patients.


Connections from

Founded Date: 2004-01-01
Investor Type: Company
Estimated Revenue: $1M to $10M
Total Funding: 20400000
Investors Number: 4
Employee Number: 51-100
Number Of Exists: 51-100
Last Funding Type: Series C
Industry: Health Care Services
Technology: AgeTech
Headquarters: Jakarta, Jakarta Raya, Indonesia
Last Funding Date: 2020